The type segmentation classifies skin closure systems into sutures, staples, adhesives, clips, and tapes, each further subdivided by material and functional characteristics. Absorbable sutures (e.g., poliglecaprone, polydioxanone) dominate the market due to their biodegradability, capturing approximately 30 % of type‑related sales. Non‑absorbable sutures (nylon, polypropylene) hold 15 % as they remain for long‑term reinforcement in orthopedic and cardiovascular settings. Metallic staples represent 20 % of revenue, favored for rapid deployment in high‑throughput general surgery, while polymeric staples add 10 % for applications requiring reduced tissue trauma. Tissue adhesives split into cyanoacrylate (12 %) and fibrin‑based (8 %) products, each addressing specific hemostasis and cosmetic outcomes. Finally, wound closure tapes and barbed sutures together occupy the remaining 5 %, serving niche markets such as dermatology and minimally invasive procedures. This detailed market taxonomy clarifies how product attributes and clinical use‑cases collectively influence the overall size and growth trajectory of the skin closure systems market.